rs150348015

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_001042432.2(CLN3):​c.238A>T​(p.Thr80Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000133 in 1,614,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T80T) has been classified as Benign.

Frequency

Genomes: 𝑓 0.00071 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000073 ( 0 hom. )

Consequence

CLN3
NM_001042432.2 missense

Scores

1
2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:2

Conservation

PhyloP100: -0.0410
Variant links:
Genes affected
CLN3 (HGNC:2074): (CLN3 lysosomal/endosomal transmembrane protein, battenin) This gene encodes a protein that is involved in lysosomal function. Mutations in this, as well as other neuronal ceroid-lipofuscinosis (CLN) genes, cause neurodegenerative diseases commonly known as Batten disease or collectively known as neuronal ceroid lipofuscinoses (NCLs). Many alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0058944523).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000709 (108/152270) while in subpopulation AFR AF= 0.00236 (98/41560). AF 95% confidence interval is 0.00198. There are 0 homozygotes in gnomad4. There are 54 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLN3NM_001042432.2 linkc.238A>T p.Thr80Ser missense_variant Exon 5 of 16 ENST00000636147.2 NP_001035897.1 Q13286-1A0A024QZB8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLN3ENST00000636147.2 linkc.238A>T p.Thr80Ser missense_variant Exon 5 of 16 1 NM_001042432.2 ENSP00000490105.1 Q13286-1

Frequencies

GnomAD3 genomes
AF:
0.000710
AC:
108
AN:
152152
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00236
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000195
AC:
49
AN:
251492
Hom.:
0
AF XY:
0.000177
AC XY:
24
AN XY:
135920
show subpopulations
Gnomad AFR exome
AF:
0.00277
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000732
AC:
107
AN:
1461870
Hom.:
0
Cov.:
30
AF XY:
0.0000646
AC XY:
47
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.00275
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000166
GnomAD4 genome
AF:
0.000709
AC:
108
AN:
152270
Hom.:
0
Cov.:
32
AF XY:
0.000725
AC XY:
54
AN XY:
74462
show subpopulations
Gnomad4 AFR
AF:
0.00236
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.0000893
Hom.:
0
Bravo
AF:
0.000763
ESP6500AA
AF:
0.00410
AC:
18
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000288
AC:
35
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Neuronal ceroid lipofuscinosis Uncertain:1Benign:1
Apr 24, 2020
Natera, Inc.
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Uncertain:1
Oct 11, 2018
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.T80S variant (also known as c.238A>T), located in coding exon 4 of the CLN3 gene, results from an A to T substitution at nucleotide position 238. The threonine at codon 80 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
May 31, 2024
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Neuronal ceroid lipofuscinosis 3 Uncertain:1
Aug 10, 2021
Genome-Nilou Lab
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

CLN3-related disorder Benign:1
Sep 07, 2022
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
0.19
DANN
Benign
0.86
DEOGEN2
Uncertain
0.63
.;D;D;.;T;.;T;D;T;.;T;.;T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.051
N
LIST_S2
Benign
0.78
T;.;.;T;.;T;T;.;T;T;T;T;T;T
M_CAP
Pathogenic
0.44
D
MetaRNN
Benign
0.0059
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.080
D
MutationAssessor
Benign
0.97
.;L;L;.;.;L;.;L;.;L;.;L;.;.
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.3
.;.;N;.;N;N;.;N;.;N;.;N;.;N
REVEL
Benign
0.25
Sift
Benign
0.26
.;.;T;.;T;T;.;T;.;T;.;T;.;T
Sift4G
Benign
0.25
.;.;.;T;T;T;.;T;.;T;.;T;.;.
Polyphen
0.010, 0.51, 0.54, 0.088
.;B;B;.;.;.;.;B;.;P;P;B;.;.
Vest4
0.27, 0.23, 0.24, 0.23, 0.26, 0.33
MVP
0.72
MPC
0.15
ClinPred
0.015
T
GERP RS
-2.6
Varity_R
0.088
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150348015; hg19: chr16-28499968; API